Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder (GAD) is one of the most common psychiatric conditions seen in both general practice and psychiatric clinics. It is characterized by persistent, excessive worry about multiple areas of daily life — work, health, family, finances, or routine responsibilities — that is disproportionate to the actual likelihood or impact of the feared events. Unlike everyday stress, which passes once a specific problem resolves, GAD worry tends to be free-floating, shifting from one concern to the next, and is accompanied by physical symptoms that can significantly affect sleep, concentration, relationships and work performance.

GAD is defined as excessive anxiety and worry occurring more days than not for at least six months, about a number of events or activities, which the person finds difficult to control. The worry is associated with physical and cognitive symptoms and causes clinically significant distress or impairment in social, occupational or other important areas of functioning.

GAD develops through an interaction of genetic vulnerability, neurobiological factors and life experience. First-degree relatives of people with GAD have a higher risk of developing an anxiety disorder, suggesting a heritable component. Early life stress, childhood adversity, overprotective or inconsistent parenting, and a temperament marked by behavioral inhibition (a tendency to be cautious, shy or easily distressed as a child) all increase vulnerability. Ongoing chronic stress — financial pressure, relationship difficulties, illness, or major life transitions — commonly triggers or worsens the disorder in someone who is already predisposed.

• Family history of anxiety disorders, depression, or other mental health conditions
• Female sex (GAD is diagnosed roughly twice as often in women as in men)
• Childhood adversity, trauma, or an anxious/overprotective family environment
• Chronic physical illness or ongoing pain
• High occupational or academic stress
• Personality traits such as perfectionism, low tolerance of uncertainty, or behavioral inhibition
• Concurrent depression, other anxiety disorders, or substance use
• Excessive caffeine intake or stimulant use, which can mimic or worsen anxiety symptoms

Neuroimaging and neurobiological research point to dysregulation in the brain's fear and threat-detection circuitry. The amygdala, which processes threat and fear signals, tends to be overactive in GAD, while the prefrontal cortex — responsible for rational appraisal and 'putting the brakes' on the amygdala's alarm response — shows reduced regulatory control. This imbalance helps explain why worry in GAD feels automatic and hard to switch off even when a person recognizes it is excessive. Neurotransmitter systems involving GABA (the brain's main calming, inhibitory chemical), serotonin, and noradrenaline are also implicated, which is part of why GABA-enhancing and serotonergic medications can be effective.

• Excessive worry about multiple things (work, health, family, finances) most days for 6+ months
• Feeling restless, keyed up, or on edge
• Becoming easily fatigued
• Difficulty concentrating or the mind 'going blank'
• Irritability
• Muscle tension, headaches, or unexplained body aches
• Sleep disturbance — difficulty falling asleep, staying asleep, or unsatisfying sleep
• Physical symptoms such as a racing heart, sweating, trembling, or gastrointestinal discomfort during periods of high anxiety

• Excessive anxiety and worry about several events or activities, occurring on most days for at least 6 months
• The person finds it difficult to control the worry
• The anxiety is associated with at least 3 of: restlessness, being easily fatigued, difficulty concentrating, irritability, muscle tension, sleep disturbance (in children, only 1 associated symptom is required)
• The symptoms cause significant distress or impair work, social, or other important functioning
• The symptoms are not better explained by another medical condition, medication, substance use, or another mental disorder

Conditions a psychiatrist will consider and rule out before confirming this diagnosis:

Major Depressive Disorder

Worry can occur in depression, but low mood, loss of interest and reduced energy are the dominant, driving features.

Panic Disorder

Anxiety comes in discrete, intense attacks with a fear of the attack itself, rather than continuous, diffuse worry.

Social Anxiety Disorder

Worry is specifically about social or performance situations and embarrassment, not free-floating across life domains.

Hyperthyroidism

Can mimic anxiety symptoms (palpitations, restlessness, weight change) — thyroid function tests help exclude this.

Caffeine or stimulant-related anxiety

Excess caffeine, decongestants, or stimulant misuse can produce anxiety symptoms that resolve once the substance is stopped.

Adjustment Disorder with Anxiety

Anxiety is a clear reaction to an identifiable stressor and typically resolves within months of the stressor easing.

• Clinical psychiatric interview and detailed history (the primary basis for diagnosis)
• Validated screening tools such as the GAD-7 questionnaire to assess severity
• Physical examination and basic blood tests (thyroid function, blood sugar, full blood count) to exclude medical causes of anxiety
• Review of caffeine, alcohol, medication and substance use history
• Screening for co-occurring depression, other anxiety disorders, or substance use, which are common alongside GAD

GAD is highly treatable. First-line treatment usually combines psychotherapy — particularly Cognitive Behavioral Therapy (CBT) — with medication when symptoms are moderate to severe, or when therapy alone is insufficient. Treatment is individualized based on symptom severity, coexisting conditions, personal preference, and past response to treatment. Most people see meaningful improvement within weeks to a few months of starting appropriate treatment, though building lasting skills to manage worry is an ongoing process.

SSRIs (e.g., sertraline, escitalopram, paroxetine)

First-line medication option; take several weeks for full effect and are generally well tolerated.

SNRIs (e.g., venlafaxine, duloxetine)

Also first-line; useful when anxiety overlaps with depression or chronic pain.

Buspirone

A non-sedating option for chronic anxiety, though slower acting than benzodiazepines.

Benzodiazepines (e.g., clonazepam, lorazepam)

Effective for short-term or acute relief but carry dependence risk, so are generally used briefly while other treatments take effect.

Pregabalin

An alternative when SSRIs/SNRIs are not tolerated or insufficiently effective.

Cognitive Behavioral Therapy (CBT)

The best-studied and most effective therapy for GAD; helps identify and restructure unhelpful worry patterns and gradually reduce avoidance.

Relaxation training and applied relaxation

Structured techniques (progressive muscle relaxation, breathing retraining) to reduce physical tension and hyperarousal.

Mindfulness-based approaches

Help build tolerance of uncertainty and reduce automatic engagement with worry thoughts.

Acceptance and Commitment Therapy (ACT)

Focuses on values-based action alongside acceptance of uncomfortable thoughts and feelings, rather than trying to eliminate them entirely.

• Maintain a regular sleep schedule and prioritize 7–9 hours of sleep
• Reduce or eliminate caffeine, especially in the afternoon and evening
• Engage in regular physical activity — even brisk walking most days measurably reduces anxiety
• Practice structured relaxation or breathing exercises daily, not just during high-anxiety moments
• Limit alcohol, which disrupts sleep and can worsen anxiety as it wears off
• Set aside a specific, time-limited 'worry period' each day rather than worrying throughout the day
• Stay connected with supportive family and friends rather than withdrawing
• Reduce exposure to rolling news or social media if it consistently increases worry

With appropriate treatment, most people with GAD experience significant symptom reduction and improved functioning. GAD tends to be a chronic condition with a fluctuating course — symptoms may wax and wane with life stress — but ongoing use of learned coping skills, and continuation or resumption of treatment during high-stress periods, allows most patients to lead full, productive lives. Untreated, GAD tends to persist and is associated with higher rates of depression, other anxiety disorders and reduced quality of life.

• Building stress-management and problem-solving skills early, especially in anxious or behaviorally inhibited children
• Addressing childhood adversity and family stress with appropriate support
• Early treatment of anxiety symptoms before they become chronic or severe
• Regular physical activity and healthy sleep habits as ongoing protective factors
• Limiting stimulant and excess caffeine use, particularly in those prone to anxiety

Family members play an important role in recovery. It helps to listen without dismissing the person's worry as 'nothing to worry about,' since the anxiety feels very real and distressing to them even when the feared outcome is unlikely. Encourage — rather than take over — daily responsibilities, since accommodating every avoidance can unintentionally reinforce the anxiety. Support treatment attendance and medication adherence, learn the basics of the CBT techniques the person is practicing so you can reinforce them at home, and seek family or couples counselling if anxiety is significantly affecting relationships.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR).
2. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11).
3. National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management.
4. National Institute of Mental Health (NIMH). Generalized Anxiety Disorder.